Mono-Anionic Phosphopeptides Produced by Unexpected Histidine Alkylation Exhibit High Plk1 Polo-Box Domain-Binding Affinities and Enhanced Antiproliferative Effects in HeLa Cells

被引:22
作者
Qian, Wen-Jian [1 ]
Park, Jung-Eun [2 ]
Lim, Dan [3 ]
Lai, Christopher C. [1 ]
Kelley, James A. [1 ]
Park, Suk-Youl [4 ]
Lee, Ki Won [4 ,5 ,6 ]
Yaffe, Michael B. [3 ]
Lee, Kyung S. [2 ]
Burke, Terrence R., Jr. [1 ]
机构
[1] NCI, Biol Chem Lab, Ctr Canc Res, NIH, Frederick, MD 21702 USA
[2] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
[3] MIT, Dept Biol & Biol Engn, Ctr Canc Res, Cambridge, MA 02139 USA
[4] Seoul Natl Univ, Adv Inst Convergence Technol, Suwon 443270, South Korea
[5] Seoul Natl Univ, World Class Univ Biomodulat Major, Seoul 151742, South Korea
[6] Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151742, South Korea
基金
美国国家卫生研究院;
关键词
Plk1; polo kinase; polo-box domain; crystal structure; cationic dialkyl histidine; intramolecular charge masking; phosphopeptides; SMALL-MOLECULE INHIBITOR; KINASE; PEPTIDE; TARGET; PRODRUGS; PHOSPHOTHREONINE; FRAGMENTATION; DISCOVERY; INSIGHTS; POSITION;
D O I
10.1002/bip.22569
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Binding of polo-like kinase 1 (Plk1) polo-box domains (PBDs) to phosphothreonine (pThr)/phosphoserine (pSer)-containing sequences is critical for the proper function of Plk1. Although high-affinity synthetic pThr-containing peptides provide starting points for developing PBD-directed inhibitors, to date the efficacy of such peptides in whole cell assays has been poor. This potentially reflects limited cell membrane permeability arising, in part, from the di-anionic nature of the phosphoryl group or its mimetics. In our current article we report the unanticipated on-resin N()-alkylation of histidine residues already bearing a N()- alkyl group. This resulted in cationic imidazolium-containing pThr peptides, several of which exhibit single-digit nanomolar PBD-binding affinities in extracellular assays and improved antimitotic efficacies in intact cells. We enhanced the cellular efficacies of these peptides further by applying bio-reversible pivaloyloxymethyl (POM) phosphoryl protection. New structural insights presented in our current study, including the potential utility of intramolecular charge masking, may be useful for the further development of PBD-binding peptides and peptide mimetics. (c) 2014 Wiley Periodicals, Inc. Biopolymers (Pept Sci) 102: 444-455, 2014.
引用
收藏
页码:444 / 455
页数:12
相关论文
共 54 条
  • [41] Inhibition of polo-like kinase 1 by blocking Polo-box domain-dependent protein-protein interactions
    Reindl, Wolfgang
    Yuan, Juping
    Kraemer, Andrea
    Strebhardt, Klaus
    Berg, Thorsten
    [J]. CHEMISTRY & BIOLOGY, 2008, 15 (05): : 459 - 466
  • [42] A Pan-Specific Inhibitor of the Polo-Box Domains of Polo-like Kinases Arrests Cancer Cells in Mitosis
    Reindl, Wolfgang
    Yuan, Juping
    Kraemer, Andrea
    Strebhardt, Klaus
    Berg, Thorsten
    [J]. CHEMBIOCHEM, 2009, 10 (07) : 1145 - 1148
  • [43] Prodrugs of biologically active phosphate esters
    Schultz, C
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (06) : 885 - 898
  • [44] A spindle checkpoint arrest and a cytokinesis failure by the dominant-negative polo-box domain of plk1 in u-2 OS cells
    Seong, YS
    Kamijo, K
    Lee, JS
    Fernandez, E
    Kuriyama, R
    Miki, T
    Lee, KS
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (35) : 32282 - 32293
  • [45] Sledz P., 2012, ANGEW CHEM, V124, P7800, DOI DOI 10.1002/ANGE.201202660
  • [46] From Crystal Packing to Molecular Recognition: Prediction and Discovery of a Binding Site on the Surface of Polo-Like Kinase 1
    Sledz, Pawel
    Stubbs, Christopher J.
    Lang, Steffen
    Yang, Yong-Qing
    McKenzie, Grahame J.
    Venkitaraman, Ashok R.
    Hyvoenen, Marko
    Abell, Chris
    [J]. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2011, 50 (17) : 4003 - 4006
  • [47] BIOREVERSIBLE PHOSPHATE PROTECTIVE GROUPS - SYNTHESIS AND STABILITY OF MODEL ACYLOXYMETHYL PHOSPHATES
    SRIVASTVA, DN
    FARQUHAR, D
    [J]. BIOORGANIC CHEMISTRY, 1984, 12 (02) : 118 - 129
  • [48] Opinion - Targeting polo-like kinase 1 for cancer therapy
    Strebhardt, K
    Ullrich, A
    [J]. NATURE REVIEWS CANCER, 2006, 6 (04) : 321 - 330
  • [50] Polo-like kinases - A team in control of the division
    van de Weerdt, Barbara C. M.
    Medema, Rene H.
    [J]. CELL CYCLE, 2006, 5 (08) : 853 - 864